This hormone is released during digestion, and help regulate blood sugar and appetite
Semaglutide clears in approximately 45 weeks due to its 7-day half-life, while tirzepatide clears in 34 weeks with a 5-day half-life
The approach works best for two populations: patients tapering to maintenance after reaching goal weight, and patients whose GI sensitivity prevents tolerating the standard 0.25 mg starting dose
The most common reasons for treatment discontinuation were gastrointestinal (GI)-related adverse events
Hwas UPenn colleagues, including Adam Vesole, MD, a neurotology fellow, are studying whether glucagon-like peptide-1 receptor agonists can play a therapeutic role in PT
The process was pretty straightforward, and fortunately, I didnt have any negative side effects